Lucemyra PI-Only Launch/Now Approved Presense May 29, 2018May 30, 2018 Brand: Lucemyra (lofexidine), Tablets Parent Company: US WorldMeds Drug Type: Prescription Drug Category: Substance Abuse Campaign: PI-Only Launch Targeting: HCPs Patient Website: https://lucemyra.com/ HCP Website: https://hcp.lucemyra.com/ Home Sign Up Mobile